Product information

From Health Canada

Current status:

Cancelled Post Market

Current status date:

2003-12-03

Original market date: See footnote 1

1996-12-31

Product name:

VIVELLE 100MCG

DIN:

02204444 Electronic product monograph is not available

Company:

NOVARTIS PHARMACEUTICALS CANADA INC
100 700 Rue Saint-Hubert
Montreal
Quebec
Canada H2Y 0C1

Class:

Human

Dosage form(s):

Patch

Route(s) of administration:

Transdermal

Number of active ingredient(s):

1

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

68:16.04 

Anatomical Therapeutic Chemical (ATC): See footnote 4

G03CA03 ESTRADIOL

Active ingredient group (AIG) number:See footnote5

0106457010

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
ESTRADIOL 8.66 MG
Version 4.0.3

"Page details"

Date modified: